Celsius Holdings heads into the final week of June with a new wrinkle in an already fraught setup: Wall Street's biggest names trimmed targets this week even as the stock touched its lowest close in months.
Short interest is now at its highest level since at least early May, and the pace of build is accelerating. Bears hold roughly 38.5 million shares — nearly 15% of free float — up 5.6% on the week and 57% over the past month. That monthly rate of accumulation has been flagged in recent notes, but the trend has not reversed. The borrow market is tightening in step. Availability has compressed sharply from above 190% just three weeks ago to 94% now — the tightest reading of the past year — meaning the pool of shares available to lend has nearly halved relative to what's already borrowed. Despite that compression, cost to borrow remains surprisingly cheap at 0.60%. Bears are not being squeezed out financially, which removes one natural ceiling on further short building. The ORTEX short score edged up again to 70.6, its highest reading in this cycle, ranking in the bottom 5th percentile of the universe. Options traders, however, still lean bullish: the put/call ratio of 0.43 is slightly above its 20-day average of 0.42, but at less than one standard deviation above, it represents no meaningful shift toward hedging. Calls continue to dominate flow. The divergence between shorts and options that defined the last two weeks has not closed.
The Street added a new dimension this week. Both BofA Securities and Morgan Stanley lowered their price targets on Tuesday and Wednesday respectively — BofA moving from $55 to $45 while maintaining Buy, Morgan Stanley from $55 to $48 while keeping Overweight. These are bellwether moves that matter. They follow Bernstein's fresh Outperform initiation at $44 two weeks ago and BNP Paribas trimming from $70 to $57 in late May. The direction of travel is consistent: every recent action is a target reduction, even from analysts keeping positive ratings. The consensus mean now stands at roughly $58.90 — still more than double the current price of $28.16 — but the gap between Street targets and market price has itself become part of the story, as repeated target cuts narrow the implied upside without changing the formal recommendation. The bull case rests on Alani brand momentum and PepsiCo distribution strength. The bear case flags conservative near-term growth in measured channels and margin risk from tariffs and distributor transitions. Factor scores add nuance: forward EPS estimates rank in the 92nd percentile for year-on-year increase, and analyst recommendation differential scores at the 99th percentile — the broadest bullish consensus in the universe — yet the short score rank sits at just the 5th percentile, the most bearish short-side positioning cohort.
Insider activity from late May remains the one concrete signal pointing toward intrinsic value. CEO John Fieldly bought 8,475 shares at $29.36 on May 22. President and COO Eric Hanson bought 7,500 shares at $29.04 on May 21. Lead independent director Hal Kravitz added 8,400 shares at $29.73 the following day. That cluster of purchases — three separate insiders, three consecutive sessions, all near current price levels — carries more weight than any single trade. The stock is now trading at $28.16, below where those purchases were made, which means the insiders who bought in late May are sitting on small losses. The 90-day net insider position is positive at roughly 40,900 shares, but modest relative to the scale of short interest building over the same period.
Earnings history provides limited comfort ahead of the August 7 Q1 print. The last three post-earnings five-day windows all produced double-digit losses: -12.3%, -12.0%, and -11.6% respectively. The single session after the most recent report was a 5.1% gain, but the five-day window erased it and more. That pattern — a brief relief pop followed by a sustained fade — is worth holding in mind as August approaches.
With availability now at its tightest level of the year, target cuts arriving from two major banks in 48 hours, and the stock drifting below where its own executives bought shares, the setup into Q1 earnings on August 7 is the next major focal point for whether the short thesis or the insider conviction resolves first.
See the live data behind this article on ORTEX.
Open CELH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
